CASI Pharmeceuticals

View All

About Us

A leading US-headquartered, NASDAQ-listed, biopharmaceutical company targeting the global market, with a focus on China.

Learn More Corporate Presentation

In the News

EntreMed leverages best of China and the West and seeks to expand pipeline.

Read Article →

Poster

Phase II Study of Oral ENMD-2076 Administered to Patients (pts) With Advanced Soft Tissue Sarcoma

Download →

Poster

Phase II Study of Oral ENMD-2076 Administered to Patients with Ovarian Clear Cell Carcinoma

Download →

Letter From the CEO

Download →

Receive press releases via email